9 results
PRE 14A
AQST
Aquestive Therapeutics Inc
18 Apr 23
Preliminary proxy
8:50am
(non-executive officers) as a group, 392,000 shares.
Retain and Incentivize our Executive Officers. We believe that the adoption of the Amendment … is important to enable us to retain and incentivize our executive officers at this critical juncture in our Company’s path. The Amendment will allow us
10-K
2018 FY
AQST
Aquestive Therapeutics Inc
14 Mar 19
Annual report
2:04pm
programs, incentivize manufacturers to lower the list price of their products, and reduce the out of pocket costs of drug products paid by consumers … of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products, and reduce the out of pocket costs of drug
424B4
bpuqds
26 Jul 18
Prospectus supplement with pricing info
4:52pm
- Prev
- 1
- Next